The early mammalian innate immune system was nature's answer to protect our children before they had an immune system of their own. Current pharmaceutical technology target's specific diseases and their attachment to our cells but does little to protect the cells from more than one pathogen.

Our patent-pending technology and products harness the power of endemic proteins, optimizing and enhancing them to perform the role for which they were designed, to protect all cells from all diseases.

Our first patent-pending product formulates the use & delivery of an ultra-pure, mammalian-sourced, innate immune system-derived bioactive protein which will help reduce the airborne transmission of coronaviruses and influenza.